Comparison of p53 and the PDZ domain containing protein MAGI-3 regulation by the E6 protein from high-risk human papillomaviruses

Virology Journal

Volumn 5, Issue , 2008, Pages

  Ainsworth, Julia ^a   Thomas, Miranda ^b   Banks, Lawrence ^b   Coutlee, Francois ^c   Matlashewski, Greg ^a  

^a MCGILL UNIVERSITY   (Canada)

^b INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; PDZ PROTEIN; PROTEASOME; PROTEIN E6; PROTEIN MAGI 3; PROTEIN MDM2; PROTEIN P53; DNA BINDING PROTEIN; E6 PROTEIN, HPV 33; E6 PROTEIN, HPV-33; E6 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; E6 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18; MAGI3 PROTEIN, HUMAN; MDM2 PROTEIN, HUMAN; ONCOPROTEIN; REPRESSOR PROTEIN; VIRUS ENVELOPE PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VIVO STUDY; PROTEIN DEGRADATION; PROTEIN DOMAIN; RISK FACTOR; UBIQUITINATION; VIRUS TYPING; WART VIRUS; CELL LINE; COMPARATIVE STUDY; DRUG ANTAGONISM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC POLYMORPHISM; METABOLISM; PAPILLOMA VIRUS; PHYSIOLOGY; SEQUENCE HOMOLOGY;

HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRIDAE;

CELL LINE; DNA-BINDING PROTEINS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; MEMBRANE PROTEINS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; POLYMORPHISM, GENETIC; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTO-ONCOGENE PROTEINS C-MDM2; REPRESSOR PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITINATION; VIRAL ENVELOPE PROTEINS;

EID: 46149125269     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-5-67     Document Type: Article

References (28)

1. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Munoz F Bosch S de Sanjose X Herrero X Castellsague V Shah P Snijders C Meijer, N Engl J Med 2003 348 518 527 10.1056/NEJMoa021641 12571259
2. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. GM Clifford JS Smith M Plummer N Munoz S Franceschi, Br J Cancer 2003 88 63 73 10.1038/sj.bjc.6600688 12556961
3. Papillomavirus E6 and E7 proteins and their cellular targets. T Wise-Draper S Wells, Front Biosci 2008 13 1003 1017 10.2741/2739 17981607
4. p53 in Health and Disease. K Vousden D Lane, Nat Rev Mel Cell Biol 2007 8 4 275 283 10.1038/nrm2147
5. Involvement of nuclear export in human papillomavirus type 18 E6-mediated ubiquitination and degradation of p53. D Stewart A Ghosh G Matlashewski, J Virol 2005 79 8773 8783 15994771 10.1128/JVI.79.14.8773-8783.2005
6. Nuclear export is required for p53 degradation by Mdm2 and human papillomavirus E6. D Freedman A Levine, Mol Cell Biol 1998 18 7288 7293 9819415
7. HPV E6 degradation of p53 and PDZ containing substrates in an E6AP null background. P Massimi A Shai P Lambert L Banks, Oncogene 2007 26 1 5 10.1038/sj.onc.1209759 16799638
8. Ubiquitin-independent degradation of p53 mediated by high-risk human papillomavirus protein E6. S Camus S Menendez CF Cheok LF Stevenson S Lain D Lane, Oncogene 2007 26 4059 4070 10.1038/sj.onc.1210188 17224909
9. HPV16 E6 confers p53-dependent and p53-independent phenotypes in the epidermis of mice deficient for E6AP. A Shai M Nguyen J Wagstaff Y Jiang P Lambert, Oncogene 2007 26 3321 3328 10.1038/sj.onc.1210130 17130828
10. Making protein interactions druggable: targeting PDZ domains. K Dev, Nat Rev Drug Discov 2004 3 1047 1053 10.1038/nrd1578 15573103
11. PDZ domains: fundamental building blocks in the organization of protein complexes at the plasma membrane. AS Fanning JM Anderson, J Clin Invest 1999 103 767 772 10079096 10.1172/JCI6509
12. Functional analysis of the guanylate kinase-like domain in the synapse-associated protein SAP97. S Kuhlendahl O Spangenberg M Konrad E Kim C Garner, Eur J Biochem 1998 252 305 313 10.1046/j.1432-1327.1998.2520305.x 9523702
13. MAGUKs in synapse assembly and function: an emerging view. JM Montgomery PL Zamorano C Garner, Cell Mol Life Sci 2004 61 911 929 10.1007/s00018-003-3364- 5 15095012
14. MAGI-1: a widely expressed, alternatively spliced tight junction protein. RP Laura S Ross H Koeppen L Lasky, Exp Cell Res 2002 275 155 170 10.1006/excr.2002.5475 11969287
15. Synaptic scaffolding molecule is involved in the synaptic clustering of neuroligin. J Iida S Hirabayashi Y Sato Y Hata, Mol Cell Neurosci 2004 27 497 508 10.1016/j.mcn.2004.08.006 15555927
16. Implication of the MAGI-1b/PTEN signalosome in stabilization of adherens junctions and suppression of invasiveness. L Kotelevets J van Hengel E Bruyneel M Mareel F van Roy E Chastre, FASEB J 2005 19 115 7 15629897
17. Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2. X Wu K Hepner S Castelino-Prabhu D Do MB Kaye XJ Yuan J Wood C Ross CL Sawyers YE Whang, Proc Natl Acad Sci USA 2000 97 4233 4238 10760291 10.1073/pnas.97.8.4233
18. Interaction of the tumor suppressor PTEN/MMAC with a PDZ domain of MAGI3, a novel membrane-associated guanylate kinase. Y Wu D Dowbenko S Spencer R Laura J Lee Q Gu LA Lasky, J Biol Chem 2000 275 21477 21485 10.1074/jbc.M909741199 10748157
19. Oncogenic human papillomavirus E6 protein targets the discs large tumour suppressor for proteasome-mediated degradation. D Gardiol C Kuhne B Glaunsinger S Lee R Javier L Banks, Oncogene 1999 18 5487 5496 10.1038/sj.onc.1202920 10523825
20. Oncogenic human papillomavirus E6 proteins target the MAGI-2 and MAGI-3 proteins for degradation. M Thomas R Laura K Hepner E Guccione C Sawyers L Lasky L Banks, Oncogene 2002 21 5088 5096 10.1038/sj.onc.1205668 12140759
21. Multi-PDZ domain protein MUPP1 is a cellular target for both adenovirus E4-ORF1 and high-risk papillomavirus type 18 E6 oncoproteins. SS Lee B Glaunsinger F Mantovani L Banks RT Javier, J Virol 2000 74 9680 9693 11000240 10.1128/JVI.74.20.9680-9693.2000
22. HPV E6 specifically targets different cellular pools of its PDZ domain-containing tumour suppressor substrates fro proteasome-mediated degradation. P Massimi N Gammoh M Thomas L Banks, Oncogene 2004 23 8033 8039 10.1038/sj.onc.1207977 15378012
23. Structures of a human papillomavirus (HPV) E6 polypeptide bound to MAGUK proteins: mechanisms of targeting tumor suppressors by a high-risk HPV oncoprotein. Y Zhang J Dasgupta RZ Ma L Banks M Thomas XS Chen, J Virol 2007 81 3618 3626 17267502 10.1128/JVI.02044-06
24. Two distinct activities contribute to human papillomavirus 16 E6's oncogenic potential. S Simonson M Difilippantonio P Lambert, Cancer Res 2005 65 8266 8273 10.1158/0008-5472.CAN-05-1651 16166303
25. The role of the ubiquitin ligase E6-AP in human papillomavirus E6-mediated degradation of PDZ domain-containing proteins. P Kuballa K Matentzoglu M Scheffner, J Biol Chem 2007 282 65 71 10.1074/jbc.M605117200 17085449
26. Ubiquitination and proteasome degradation of the E6 proteins of human papillomavirus types 11 and 18. D Stewart S Kazemi S Li P Massimi L Banks AE Koromilas G Matlashewski, J Gen Virol 2004 85 1419 1426 10.1099/vir.0.19679-0 15166424
27. Human papillomavirus type 33 polymorphisms and high-grade squamous intraepithelial lesions of the uterine cervix. S Khouadri LL Villa S Gagnon A Koushik H Richardson S Ferreira P Tellier J Simao G Matlashewski M Roger EL Franco F Coutlee, J Infect Dis 2006 194 886 894 10.1086/507431 16960775
28. Interaction of the Tumor Suppressor PTEN/MMAC with a PDZ Domain of MAGI3, a Novel Membrane-associated Guanylate Kinase. W Yan D Dowbenko S Spencer R Laura J Lee Q Gu L Lasky, J Biol Chem 2000 275 21477 21485 10.1074/jbc. M909741199 10748157